biosimilar Archives - Page 2 of 7 -

Mylan’s Lantus biosimilar held up by manufacturing issue

https://pharmaphorum.com/news/mylans-lantus-biosimilar-held-up-by-manufacturing-issue/

https://pharmaphorum.com/news/lilly-faces-biosimilar-rivals-to-osteoporosis-drug-forsteo-in-europe/

J&J faces FTC probe on Remicade biosimilar defence

https://pharmaphorum.com/news/jj-faces-ftc-probe-on-remicade-biosimilar-defence/

Roche raises 2019 outlook, shrugging off biosimilar threat

https://pharmaphorum.com/news/roche-raises-2019-outlook-shrugging-off-biosimilar-threat/

New deals extend Mundipharma biosimilar reach

https://pharmaphorum.com/news-market-access/new-deals-extend-mundipharma-biosimilar-reach/

FDA approves Samsung/Merck & Co’s Herceptin biosimilar

https://pharmaphorum.com/news/fda-approves-samsung-merck-cos-herceptin-biosimilar/

Mylan and Fujifilm join Humira bunfight as fifth EU biosimilar approved

https://pharmaphorum.com/news/mylan-and-fujifilm-biosimilar-approved/

Allergan buys Bonti and its Botox successor, as biosimilar looms

https://pharmaphorum.com/news/allergan-buys-bonti-and-its-botox-successor-as-biosimilar-looms/

Biosimilars underused in rheumatoid arthritis on the NHS – experts

https://pharmaphorum.com/news/biosimilars-underused-rheumatoid-arthritis-nhs-experts/

Search